Substrate specificity of antinuclear antibodies in scleroderma.

Antinuclear antibodies in children.

Antinuclear antibodies in rosacea patients.

Positive antinuclear antibodies in malignancies.

Absorption of serum antinuclear antibodies.

Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.

Antinuclear antibody with distinct specificity for polymyositis.

Antinuclear antibodies in patients on lithium carbonate.

Antinuclear antibodies in patients taking L1.

Antinuclear antibodies in sickle cell disease.

In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies.

[Antinuclear antibodies: what dermatologists need to know].

Drug-induced antinuclear antibodies and lupus syndromes.

Antiphospholipid antibodies and systemic scleroderma.

Antinuclear antibodies in neuromyelitis optica: guardians of the brain?

High prevalence of antinuclear antibodies in children with thyroid autoimmunity.

Antinuclear antibodies in sera of patients with recurrent pregnancy wastage.

Antinuclear antibodies in patients receiving non-practolol beta-blockers.

Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Oral lichenoid lesions and serum antinuclear antibodies in Thai patients.

Substrate specificity of vetebrate collagenase.

Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.

Serum renin and renin substrate levels in scleroderma.

Leucocyte specific antinuclear antibodies. Preparation and fluorescence study.

Antinuclear antibodies during procainamide treatment and drug acetylation.

Suggest Documents

Antinuclear antibodies in children.

Antinuclear antibodies in rosacea patients.

Positive antinuclear antibodies in malignancies.

Absorption of serum antinuclear antibodies.

Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.

Antinuclear antibody with distinct specificity for polymyositis.

Antinuclear antibodies in patients on lithium carbonate.

Antinuclear antibodies in patients taking L1.

Antinuclear antibodies in sickle cell disease.

In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies.

[Antinuclear antibodies: what dermatologists need to know].

Drug-induced antinuclear antibodies and lupus syndromes.

Antiphospholipid antibodies and systemic scleroderma.

Antinuclear antibodies in neuromyelitis optica: guardians of the brain?

High prevalence of antinuclear antibodies in children with thyroid autoimmunity.

Antinuclear antibodies in sera of patients with recurrent pregnancy wastage.

Antinuclear antibodies in patients receiving non-practolol beta-blockers.

Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Oral lichenoid lesions and serum antinuclear antibodies in Thai patients.

Substrate specificity of vetebrate collagenase.

Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.

Serum renin and renin substrate levels in scleroderma.

Leucocyte specific antinuclear antibodies. Preparation and fluorescence study.

Antinuclear antibodies during procainamide treatment and drug acetylation.

Substrate specificity of antinuclear antibodies in scleroderma.

Recommend Documents

Follow Us